ebook Munafa Stock Market Course + Intraday & FNO calls  

       

NBIX announcements Neurocrine Biosciences, Inc. announcements and dividends declared USA

Neurocrine Biosciences, Inc. Complete list of announcements declared & dividend announcements by Neurocrine Biosciences, Inc. NBIX

Neurocrine Biosciences, Inc. NBIX listed on USA and deals in Health Care Biotechnology Biological Products No Diagnostic Substances

Announcements and dividends declared by Neurocrine Biosciences, Inc. NBIX

: Neurocrine Biosciences price target raised at Oppenheimer after FDA approves movement disorder treatment
Neurocrine Biosciences Inc. NBIX said Friday that the U.S. Food and Drug Administration has approved Ingrezza for treatment of an involuntary movement disorder linked with Huntington’s disease, prompting analysts at Oppenheimer to boost their price targ
Announcement as on 21 August 2023

Bear of the Day: Neurocrine Biosciences (NBIX)
Neurocrine Biosciences NBIX is an .5 billion neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders.The company's neuroscience, endocr
Announcement as on 28 February 2022

Bear of the Day: Neurocrine Biosciences (NBIX)
Neurocrine Biosciences NBIX is an .5 billion neuroscience-based company focused on the discovery and development of novel therapeutics for neuropsychiatric, neuroinflammatory and neurodegenerative diseases and disorders.The company's neuroscience, endocr
Announcement as on 28 February 2022

Neurocrine Biosciences, Inc. Shares Near 52-Week Low - Market Mover
Neurocrine Biosciences, Inc. (NBIX) shares closed today at 0.3% above its 52 week low of .50, giving the company a market cap of B. The stock is currently down 9.3% year-to-date, down 9.0% over the past 12 months, and up
Announcement as on 30 November 2021

Neurocrine Biosciences, Inc (NBIX) Q3 2021 Earnings Call Transcript
Image source: The Motley Fool.
Announcement as on 02 November 2021

Announcements by Neurocrine Biosciences, Inc. first page | Next page |

NBIX Neurocrine Biosciences, Inc. current price & indicator signals

Moving Averages for Neurocrine Biosciences, Inc.

  • 5Day Average: 131.77
  • 12Day Average: 130.59
  • 20Day Average: 131.1
  • 50Day Average: 135.06
  • 100Day Average: 140.59
  • 150Day Average: 139.58
  • 200Day Average: 136.64

NBIX Indicators & signals

Indicator MACD (12,26,9)

131.14, 132.34, -1.72
Indicator MACD is in negative zone

Indicator ADX (14)

6.25, 19.23, 21.79
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 42
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of NBIX Neurocrine Biosciences, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
05 Thu Mar 2026 129.64 129.22 to 133.00 -2.85% 1.46 times
04 Wed Mar 2026 133.44 131.01 to 134.83 1.75% 1.29 times
03 Tue Mar 2026 131.14 128.00 to 132.42 -0.94% 0.83 times
02 Mon Mar 2026 132.38 130.32 to 133.25 0.1% 0.96 times
27 Fri Feb 2026 132.25 129.09 to 132.99 1.23% 1.23 times
26 Thu Feb 2026 130.64 128.93 to 132.20 -0.39% 0.78 times
25 Wed Feb 2026 131.15 130.02 to 132.25 0.15% 0.86 times
24 Tue Feb 2026 130.96 128.03 to 131.38 2.01% 0.93 times
23 Mon Feb 2026 128.38 126.59 to 128.79 -0.19% 0.96 times
20 Fri Feb 2026 128.63 127.16 to 130.35 -1.13% 1.01 times
19 Thu Feb 2026 130.10 127.79 to 130.98 1.34% 1.16 times
18 Wed Feb 2026 128.38 126.02 to 128.87 0.49% 1.02 times

Videos related to: NBIX announcements Neurocrine Biosciences, Inc. announcements and dividends declared USA

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

NBIX announcements Neurocrine Biosciences, Inc. announcements and dividends declared USA

 

Back to top